Neuroimaging plays an important role in the adjunctive diagnosis of psychiatric disorders. Ace Therapeutics is committed to providing innovative solutions for the early diagnosis and treatment of psychiatric disorders. Our neuroimaging diagnostic method development service focuses on the development and optimization of diagnostic methods for psychiatric disorders. Our service combines advanced neuroimaging techniques and biomarker studies to improve the diagnostic accuracy of psychiatric disorders and provide a scientific basis for personalized treatment.

Neuroimaging in The Diagnosis of Psychiatric Disorders

Neuroimaging methods provide an ever-expanding set of tools to examine the brain networks underlying neuropsychiatry. Applications of neuroimaging techniques in the diagnosis of psychiatric disorders include, but are not limited to, the following:

• Neuroimaging helps to make a proper determination of psychiatric symptoms.
• Neuroimaging techniques can capture molecular and cellular disease targets or phenotypic variants in brain circuits, which can help detect structural lesions that cause psychiatric disorders.
• Neuroimaging techniques can distinguish psychiatric disorders such as depression from neurodegenerative diseases or brain tumors.

Our Neuroimaging Diagnostic Methods Development Services for Psychiatric Disorders

• Neuroimaging biomarker development and validation

The amygdala, thalamus, hippocampus, dorsolateral prefrontal cortex, and insula play important roles in neuropsychiatric functioning. Ace Therapeutics focuses on identifying and validating neuroimaging biomarkers associated with psychiatric disorders in these brain-related regions.

We identify and validate neuroimaging features associated with specific psychiatric disorders with the help of animal models of psychiatric disorders and using advanced neuroimaging and data analysis techniques. By collecting and analyzing large-scale neuroimaging datasets, we explore characteristic changes in brain structure, function, and connectivity patterns associated with different psychiatric disorders to ensure that specific imaging candidate diagnostic markers are developed for our clients.

• Developing brain-based, data-driven diagnostic programs

We develop brain-based, data-driven diagnostics utilizing MRI, fMRI, PET and DTI, EEG, and other neuroimaging techniques to facilitate early diagnosis of psychiatric disorders.

Advantages of Ace Therapeutics

• Our team of professionals is well-versed in neuroscience, imaging, and data science.
• We provide detailed information about the structure and function of the brain through a variety of advanced neuroimaging techniques such as magnetic resonance imaging (MRI), electroencephalography (EEG), magnetoencephalography (MEG), and positron emission tomography (PET).
• Comprehensive analysis of neuroimaging data from different sources and in-depth mining of potential neuro-targets and biomarkers provide reliable and specific markers for the diagnosis of psychiatric disorders.

Ace Therapeutics is committed to applying our expertise and extensive experience to provide you with a specific neuroimaging approach in the diagnosis of psychiatric disorders. Please contact us for more details and we will be happy to assist you.